DUBLIN–(BUSINESS WIRE)–The “Interventional Neurology Market Analysis by Product (Cerebral Balloon Angioplasty and Stenting Systems, Aneurysm Coiling & Embolization Devices), by Disease (Arteriovenous Malformation and Fistulas, Cerebral Aneurysms, Ischemic Strokes), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global interventional neurology market size is estimated to be USD 2,702.4 million in 2021 and is expected to witness a CAGR of 9.25% to 2029
Enormous global target patient population is a key driver for the growth of the global interventional neurology market. Additionally, continuous product and technology development along with commercialization, growth in demand for effective neurovascular devices, and favourable medical compensations in the market are some of the other drivers propelling the market growth.
Nevertheless, shortage of trained professionals, stringent regulatory framework related to new technology development, and high cost of neurological treatment are expected to restrain the global market growth.
By Product
In 2021, the aneurysm coiling and embolization devices segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
This is due to the patient’s inclination towards minimally invasive neurosurgical procedures and increase in availability of embolic coils for neurovascular treatment worldwide. The cerebral balloon angioplasty and stenting systems segment is anticipated to grow at a profitable CAGR during the forecast period, due the launch of new products driving the market worldwide.
By Disease
In 2021, the ischemic strokes segment accounted for the substantial revenue share with lucrative CAGR during the forecast period.
This is due to rise in cases of ischemic stroke globally and increasing patient partiality for minimally invasive surgeries worldwide. The cerebral aneurysms segment is anticipated to grow at a profitable CAGR during the forecast period, due to continuing technological advancements and growth in target patient population.
Regional Insights
In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the increase in the number of patients suffering from Alzheimer’s, requirement for minimally invasive technologies, and increase in prevalence of neurological disorders in the region.
Asia Pacific market is projected to exhibit the fastest CAGR over the forecast period owing to the growing government and private investment in healthcare sector, increasing establishment of new manufacturing plants in the region, and availability of skilled labour forces at economic costs, are the major factors in this region.
Competitor Insights
The leading players operating in the interventional neurology industry are adopting various strategies including R&D investments, adaption of advanced techniques, new technology launches, mergers & acquisitions, and regional expansions to capture a maximum revenue share.
Company Profiles
- Stryker Corporation (U.S.)
- Medtronic plc (U.S.)
- Johnson & Johnson (U.S.)
- Terumo Corporation (Japan)
- Penumbra Inc. (U.S.)
- Abbott Laboratories (U.S.)
- Merit Medical Systems Inc. (U.S.)
- W. L. Gore & Associates Inc. (U.S.)
- MicroPort Scientific Corporation (China)
- B. Braun Melsungen AG (Germany)
Interventional Neurology Market, By Product (Revenue, USD Million, 2021 – 2029)
Cerebral Balloon Angioplasty and Stenting Systems
- Carotid Artery Stents
- Embolic Protection Systems
- Distal Filter Devices
- Balloon Occlusion Devices
Aneurysm Coiling & Embolization Devices
- Embolic Coils
- Bare Detachable Coils
Coated Detachable Coils
- Flow Diversion Devices
- Liquid Embolic Agents
Support Devices
- Microcatheters
- Micro guidewires
Neurothrombectomy Devices
- Clot Retrieval Devices
- Suction and Aspiration Devices
- Snares
Interventional Neurology Market, By Disease (Revenue, USD Million, 2021 – 2029)
- Arteriovenous Malformation and Fistulas
- Cerebral Aneurysms
- Ischemic Strokes
- Other Disease Pathologies
Interventional Neurology Market, By Region (Revenue, USD Million, 2021 – 2029)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
For more information about this report visit https://www.researchandmarkets.com/r/co2put
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
